
### [MONDO:0000013](http://purl.obolibrary.org/obo/MONDO_0000013)
**Label:** choroidal dystrophy

**Subclasses:** [MONDO:0013151](http://purl.obolibrary.org/obo/MONDO_0013151) (CACD3), [MONDO:0008982](http://purl.obolibrary.org/obo/MONDO_0008982) (central areolar choroidal dystrophy), [MONDO:0013137](http://purl.obolibrary.org/obo/MONDO_0013137) (choroidal dystrophy, central areolar 2), 

**Mapped go classes:** [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization), 

**Class expressions from DL-Learner:**

- [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization) 56.25%
- [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble) 56.25%
- [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process) 56.25%
- [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding) 56.25%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 56.25%
- [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity) 56.25%
- [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment) 56.25%
- [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 56.25%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0001883](http://purl.obolibrary.org/obo/GO_0001883) (purine nucleoside binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) and [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process) 56.25%
- [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process) and [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 56.25%
- [GO:0009260](http://purl.obolibrary.org/obo/GO_0009260) (ribonucleotide biosynthetic process) and [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 56.25%


